Phase 1 Clinical Trial of Varenicline in Chinese Healthy Smoking Volunteers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00452894|
Recruitment Status : Completed
First Posted : March 28, 2007
Last Update Posted : April 1, 2008
|Condition or disease||Intervention/treatment||Phase|
|Smoking||Drug: varenicline tartrate||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||14 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Pharmacokinetic, Toleration And Safety Study Of Single And Multiple Oral Doses Of Varenicline In Chinese Healthy Volunteers|
|Study Start Date :||March 2007|
|Actual Study Completion Date :||March 2007|
- The PK parameters after a single dose and PK parameters after 7 days of multiple dosing respectively.
- To gather safety data from Day 0 to Day 17 of the study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00452894
|Pfizer Investigational Site|
|Study Director:||Pfizer CT.gov Call Center||Pfizer|